Beverly A. Smith

4.8k total citations · 1 hit paper
36 papers, 3.5k citations indexed

About

Beverly A. Smith is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Beverly A. Smith has authored 36 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Cancer Research. Recurrent topics in Beverly A. Smith's work include Carcinogens and Genotoxicity Assessment (9 papers), Blood Pressure and Hypertension Studies (8 papers) and Hormonal Regulation and Hypertension (8 papers). Beverly A. Smith is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Blood Pressure and Hypertension Studies (8 papers) and Hormonal Regulation and Hypertension (8 papers). Beverly A. Smith collaborates with scholars based in United States, United Kingdom and Italy. Beverly A. Smith's co-authors include Alberto Zanchetti, Steffan Ekman, Michael A. Weber, John H. Laragh, Hans R. Brunner, Gordon T. McInnes, Sverre E. Kjeldsen, Stevo Julius, Francis Plat and Tsushung A. Hua and has published in prestigious journals such as The Lancet, Circulation and The Journal of Immunology.

In The Last Decade

Beverly A. Smith

36 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2004 1.8k citations Stevo Julius, Sverre E. Kjeldsen et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beverly A. Smith United States	20	2.6k	1.4k	456	337	290	36	3.5k
W.J. Howard United States	23	1.1k 0.4×	1.8k 1.3×	1.5k 3.3×	365 1.1×	483 1.7×	70	3.9k
Chiara Giannarelli United States	34	1.3k 0.5×	401 0.3×	490 1.1×	207 0.6×	687 2.4×	88	3.1k
Paul-J. Lupien Canada	19	757 0.3×	1.5k 1.1×	1.1k 2.3×	157 0.5×	437 1.5×	31	3.0k
Lοukianos S. Rallidis Greece	29	1.5k 0.6×	454 0.3×	931 2.0×	324 1.0×	282 1.0×	172	3.3k
J. D. Knoke United States	11	695 0.3×	1.7k 1.2×	1.6k 3.4×	173 0.5×	363 1.3×	22	3.2k
Giuliano Tocci Italy	32	2.1k 0.8×	700 0.5×	475 1.0×	408 1.2×	364 1.3×	212	3.7k
Jari Stengård Finland	24	779 0.3×	1.4k 1.0×	1.6k 3.5×	363 1.1×	1.2k 4.2×	52	5.0k
Marguerite R. Irvin United States	30	922 0.4×	503 0.4×	321 0.7×	321 1.0×	1.2k 4.2×	159	3.2k
Fred H. Faas United States	18	866 0.3×	2.1k 1.6×	2.0k 4.5×	315 0.9×	798 2.8×	47	4.0k
Rafael Carmena Spain	32	911 0.4×	2.1k 1.5×	2.1k 4.6×	266 0.8×	697 2.4×	154	4.6k

Countries citing papers authored by Beverly A. Smith

Since Specialization

Citations

This map shows the geographic impact of Beverly A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Smith more than expected).

Fields of papers citing papers by Beverly A. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Smith. The network helps show where Beverly A. Smith may publish in the future.

Co-authorship network of co-authors of Beverly A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Smith. A scholar is included among the top collaborators of Beverly A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Smith. Beverly A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pitt, Bertram, Roberto Latini, Aldo P. Maggioni, et al.. (2011). Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study. European Journal of Heart Failure. 13(7). 755–764. 20 indexed citations

Jackson, Colette E., Michael R. MacDonald, Mark C. Petrie, et al.. (2011). Associations of Albuminuria in Patients with Chronic Heart Failure: Findings in the ALiskiren Observation of Heart Failure Treatment Study. European Journal of Heart Failure. 13(7). 746–754. 27 indexed citations

Pouleur, Anne–Catherine, Hajime Uno, Margaret F. Prescott, et al.. (2011). Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 12(4). 483–490. 15 indexed citations

O’Brien, Denise, Mary Lou V. H. Greenfield, Jane Anderson, Beverly A. Smith, & Michelle Morris. (2010). Comfort, Satisfaction, and Anxiolysis in Surgical Patients Using a Patient-Adjustable Comfort Warming System: A Prospective Randomized Clinical Trial. Journal of PeriAnesthesia Nursing. 25(2). 88–93. 22 indexed citations

Weber, Michael A., Stevo Julius, Sverre E. Kjeldsen, et al.. (2004). Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. The Lancet. 363(9426). 2049–2051. 428 indexed citations

Warren, Amye R., et al.. (2002). The believability of children and their interviewer's hearsay testimony: When less is more.. Journal of Applied Psychology. 87(5). 846–857. 11 indexed citations

Hofmann‐Lehmann, Regina, Robert A. Rasmussen, Josef Vlasak, et al.. (2001). Passive immunization against oral AIDS virus transmission: An approach to prevent mother‐to‐infant HIV‐1 transmission?. Journal of Medical Primatology. 30(4). 190–196. 28 indexed citations

Kjeldsen, Sverre E., Stevo Julius, Hans R. Brunner, et al.. (2001). Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial. Blood Pressure. 10(2). 83–91. 67 indexed citations

Mittelstaedt, Roberta A., Beverly A. Smith, Tao Chen, Frederick A. Beland, & Robert H. Heflich. (1999). Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluorene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 431(1). 167–173. 6 indexed citations

10.

Beland, Frederick A., Nancy F. Fullerton, Beverly A. Smith, Roberta A. Mittelstaedt, & Robert H. Heflich. (1999). Hprt lymphocyte mutant frequency in relation to DNA adduct formation in rats fed the hepatocarcinogen 2-acetylaminofluorene. Cancer Letters. 143(2). 249–255. 4 indexed citations

11.

Masuda, Akihiro, et al.. (1997). Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunological Reviews. 156(1). 185–197. 51 indexed citations

12.

Smith, Beverly A., Mugimane G. Manjanatha, Igor P. Pogribny, et al.. (1997). Analysis of mutations in the K-ras and p53 genes of lung tumors and in the hprt gene of 6-thioguanine-resistant T-lymphocytes from rats treated with 1,6-dinitropyrene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 379(1). 61–68. 13 indexed citations

13.

Lichtenstein, Benyamin M. Bergmann, Beverly A. Smith, & William R. Torbert. (1995). Leadership and Ethical Development. Business Ethics Quarterly. 5(1). 97–116. 7 indexed citations

14.

Poirier, Miriam C., Nancy F. Fullerton, Beverly A. Smith, & Frederick A. Beland. (1995). DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis. 16(12). 2917–2921. 40 indexed citations

15.

Mittelstaedt, Roberta A., Beverly A. Smith, & Robert H. Heflich. (1995). Analysis of in vivo mutation induced by N‐ethyl‐N‐nitrosourea in the hprt gene of rat lymphocytes. Environmental and Molecular Mutagenesis. 26(4). 261–269. 45 indexed citations

16.

Smith, Beverly A., et al.. (1995). DNA adduct formation and T-lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.. PubMed. 55(11). 2316–24. 28 indexed citations

17.

Wang, Yichang, et al.. (1991). Kinds of mutations found when a shuttle vector containing adducts of 1,6-dinitropyrene replicates in human cells. Carcinogenesis. 12(1). 119–126. 21 indexed citations

18.

Poirier, Miriam C., Nancy F. Fullerton, Takemi Kinouchi, Beverly A. Smith, & Frederick A. Beland. (1991). Comparison between DNA adduct formation and turmorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorence. Carcinogenesis. 12(5). 895–900. 53 indexed citations

19.

Smith, Beverly A. & Helmut R. Gutmann. (1984). Differential effect of chronic ethanol consumption by the rat on microsomal oxidation of hepatocarcinogens and their activation to mutagens. Biochemical Pharmacology. 33(18). 2901–2910. 6 indexed citations

20.

Khuri, Shukri F., Miguel Josa, William A. Marston, et al.. (1983). II. Assessment of adequacy of myocardial preservation. Journal of Thoracic and Cardiovascular Surgery. 86(5). 667–678. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact